Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tissue Plus
AddedFeb 17, 2024
UpdatedJun 18, 2026
Tissue Plus

Tissue Plus

Angel

Maine-based Tissue Plus manufactures diverse interfold products, offering custom packaging solutions on advanced machinery.

HQ
Bangor, ME, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded in Bangor, Maine, Tissue Plus is dedicated to manufacturing a diverse range of interfold products. The company's core mission is to be a high-quality, low-cost producer by leveraging automation, technology, and innovative business solutions. Tissue Plus offers custom packaging solutions for both commodity and specialty finished goods, catering to private label customers and brands. Their market focus includes both "At Home" and "Away From Home" segments, providing versatile paper products to meet varied budgets.

Notable affiliated people and investors are not specified, but Tissue Plus has achieved recognition for its commitment to quality, service, and value. Utilizing state-of-the-art machinery, the company has successfully positioned itself as a reliable provider of premium paper products. Their impact is evident in their ability to deliver value-added solutions that cater to diverse customer needs, reinforcing their reputation in the paper manufacturing industry.

Tissue Plus - Quick Facts

When was Tissue Plus founded?

Tissue Plus was founded in 2019.

Where is Tissue Plus' headquarters located?

Tissue Plus' headquarters is located in Bangor, ME, US.

When was Tissue Plus' last funding round?

Tissue Plus' most recent funding round was for $100k (USD) in January 2020.

How much has Tissue Plus raised to-date?

As of Jan 1, 2020, Tissue Plus has raised a total of $100k (USD).

How many employees does Tissue Plus have?

Tissue Plus has 50 employees as of Feb 4, 2024.

Tissue Plus - Classification

Industry
  • Retail
Technology
  • Automation
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
  • Enterprise
Main Product
  • Packaging
  • Paper Products
Tags
  • Distribution
  • Manufacturing
NAICS
  • 330000Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries